Ain Holdings Inc. · TSE:9627
Ain — Q3 FY4/21 Earnings Presentation
19 slides from Ain's earnings presentation, March 2021
Slide 1: FY4/21 3Q IR Presentation
FY4/21 3Q IR PRESENTATION March 2021
Slide 2: Results Overview
Results Overview © 2021 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales was almost flat YoY and decreased 0.4% against the plan due to the contribution of 22 stores opened(including M&A) in this fiscal year and store opened in previous year, despite the impact of the COVID-19. Ordinary income declined 39.7% YoY due to lower gross profit margin
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales decreased 1.3% YoY and 0.4% against the plan due to the impact of the COVID-19 outbreak. Segment income declined 11.6% YoY due to decrease of net sales and up 4.3% against the plan due to reduction of administrative expense. FY4/20 3Q FY4/21 3Q F
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales declined 28.3% YoY and up 0.2% against the plan due to temporarily closed or shorted opening hours at many stores, despite the group has opened 7 stores in this fiscal year. Segment loss was ¥1,507 million due to net sales declined. FY4/20 3Q
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥42,043 million and shareholders’ equity ratio became 57.2%. We are maintaining a sound financial structure even during the COVID-19 outbreak. (¥ million) (¥ million) End-FY4/20 End-FY4/21 3Q Assets Liabilities Assets Liabilities Current assets 74,700 Current assets
Slide 7: Assets
Assets The balance of total assets increased ¥5,321 million from the end of the previous fiscal year due to increase of cash on hand and in banks. End-FY4/20 3Q End-FY4/20 End-FY4/21 3Q Change (¥ million) Cash on hand and in banks 46,276 46,321 54,756 +8,435 Notes and accounts receivable 13,713 13,6
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets The balance of liabilities increased ¥2,667 million from the end of the previous fiscal year due to increase of long-term debt for investment purpose. (¥ million) End-FY4/20 3Q End-FY4/20 End-FY4/21 3Q Change Accounts payable 46,784 47,187 46,700 (487) Short-term debt 4,19
Slide 9: FY4/21 Plan (Consolidated)
FY4/21 Plan (Consolidated) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales increase 2.5% and ordinary income decrease 40.6% YoY due to the prolonged impact of the COVID-19. FY4/20 FY4/21 YoY change YoY change （¥ million） results plan (%) Net sales 292,615 300,
Slide 10: FY4/21 Plan (Dispensing Pharmacy Business)
FY4/21 Plan (Dispensing Pharmacy Business) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales increase 0.4% and segment income decrease 12.7% YoY due to the prolonged impact of the COVID-19. FY4/20 FY4/21 YoY change YoY change (¥ million) results plan (%) Net sal
Slide 11: FY4/21 Plan (Cosmetic and Drug Store Business)
FY4/21 Plan (Cosmetic and Drug Store Business) The group has revised the forecast for the fiscal year ending April 30, 2021. Net sales decrease 19.0% and segment loss of ¥2,200 million due to the prolonged impact of the COVID-19. FY4/20 FY4/21 YoY change YoY change (¥ million) results plan (%) Net s
Slide 12: Review
Review © 2021 AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Daily new COVID-19 cases across Japan
Daily new COVID-19 cases across Japan As of March 1, the number of domestic cases of the COVID-19 infection and deaths was 433,504 and 7,933, respectively. （people） 9,000 No. of positive cases Nov.24－Dec.15 Dec.28－ 8,000 Osaka and Sapporo excluded from Temporarily suspended the Go To Travel campaign
Slide 14: Review (YoY)
Review（YoY） Ordinary income decreased 5.2 billion because declined net sales couldn’t absorb store opening costs and labor costs for new employee. Net sales ¥0.1 billion Ordinary income ¥(5.2) billion ¥220.0 billion ¥220.1 billion ¥13.0 billion Dispensing Dispensing ¥7.8 billion Pharmacy Pharmacy Di
Slide 15: Review (Vs plan)
Review（Vs plan） Net sales fell 0.8 billion against the plan due to the impact of the COVID-19 outbreak, while ordinary income increased 0.8 billion against the plan due to cost reduction. Net sales ¥(0.8) billion Ordinary income +¥0.8 billion ¥220.9 billion ¥220.1 billion Dispensing Dispensing ¥7.8
Slide 16: Strategy
Strategy Expansion of Top-line ■Dispensing Pharmacy Expanding of opening large-scale pharmacies including M&A ■Cosmetic and Drug Store Accelerate opening stores in satellite cities Proper staffing ■Active recruitment of newly graduate pharmacists ■Assign personnel properly and strengthening recruitm
Slide 17: Opening
Top-line The group opened 22 stores including M&A, and closed 51 stores during the FY4/21 3Q. ■ Total number of stores 1,122 (Dispensing pharmacy:1,057、Cosmetic and drug store:65) FY4/21 3Q FY4/21 ■ Plan Hokkaido Plan Results Revised plan 121 Dispensing 14 15 38 Pharmacy Opening Organic 8 8 16 Koshi
Slide 18: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha
Slide 19: AIN GROUP
AIN GROUP